Bio-Rad Laboratories, Inc. Class A Common Stock vs D R Horton Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while D R Horton Inc trades at $150.79 (market cap $42.18B). The key difference: D R Horton Inc is far larger — about 4.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and D R Horton Inc pays a 1.19% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | DHI | |
|---|---|---|
Market Cap | $9.43B | $42.18B |
Sector | Health | Consumer Cyclical |
52-Week High | $356.25 | $184.04 |
52-Week Low | $241.71 | $132.53 |
Enterprise Value | $9.18B | $47.28B |
Dividend Yield | — | 1.19% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →